-
Posted by
Two Blokes 7 hours ago -
Filed in
Stock
-
0 views
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announced plans to offer broad, affordable, and streamlined access to Wegovy\u00ae (semaglutide) through NovoCare\u00ae Pharmacy. This integration offers a simplified pathway for cash-pay patients to access all FDA-approved dose strengths of Wegovy\u00ae directly within LifeMD's virtual care platform.
